The number of lawsuits over violent acts committed under the influence of antidepressants, which “caused such angst for companies such as Eli Lilly and Co.,” have “pretty much subsided,” reports the Indianapolis Star. While use of the drugs “is as widespread as ever,” the number of suits has fallen off because of the FDA’s decision 10 years ago to require a “black box” warning about the link between antidepressants and suicidal behavior. Another reasons for the decline, reports the Star, is that the most popular antidepressants have lost patent protection. Lilly was “once the focus” of this type of litigation, but is “largely removed from it” now that Prozac and Cymbalta have gone off-patent and have “faded in significance for the company.”
From the news release of the American Association for Justice.
